Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 76 of 675 for:    applied AND web-

Initial Development and Dissemination of OC-Go (OC-GoPhaseI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03126305
Recruitment Status : Enrolling by invitation
First Posted : April 24, 2017
Last Update Posted : June 18, 2018
Sponsor:
Collaborator:
Virtually Better, Inc.
Information provided by (Responsible Party):
John Piacentini, University of California, Los Angeles

Tracking Information
First Submitted Date April 19, 2017
First Posted Date April 24, 2017
Last Update Posted Date June 18, 2018
Estimated Study Start Date July 1, 2018
Estimated Primary Completion Date February 1, 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: April 19, 2017)
  • System Usability Scale (SUS) [ Time Frame: 6 weeks ]
    10-item self-report measure assessing the usability of the OC-Go application
  • Usability Evaluation for e-Learning Applications (UELA), [ Time Frame: 6 weeks ]
    54-item self-report measure assessing the usability of the OC-Go application
Original Primary Outcome Measures Same as current
Change History Complete list of historical versions of study NCT03126305 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Initial Development and Dissemination of OC-Go
Official Title Facilitating Fidelity and Dissemination of Evidence Based Treatment for Childhood OCD Via an Interactive Crowd-sourced Patient-provider Tool
Brief Summary The clinical component of Phase I application development examines the clinical utility, feasibility, and functionality of the OC-Go application via an 8-month pilot trial consisting of 50 standard CBT sessions augmented with OC-Go in OCD-diagnosed children who are receiving treatment through the pediatric OCD treatment programs in the UCLA Division of Child and Adolescent Psychiatry
Detailed Description This project seeks to refine and assess OC-Go, a HIPAA-compliant web-based clinician portal and patient-side mobile application designed to increase patient adherence to evidence-based treatment (EBT) for Obsessive Compulsive Disorder (OCD), a common and impairing condition, and provider ability to effectively implement EBTs. OC-Go allows clinicians to create and push tailored assignments to patients on their mobile devices with an optimized user interface that includes patient accountability and support features. Accordingly, patients can be guided to do assignments by themselves between sessions with increased fidelity over the course of treatment. Once therapy assignments are created and shared to a crowd-sourced and curated public library, any clinician can assign any task to any patient for homework or in-session use with one touch. Use of OC-Go is expected to increase patient engagement, compliance, treatment efficiency, dissemination of EBTs, and therapist confidence and expertise.
Study Type Observational
Study Design Observational Model: Ecologic or Community
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Children receiving exposure based CBT through the UCLA Child OCD, Anxiety and Tic Disorders Clinic or Pediatric OCD Intensive Outpatient Program and their parents
Condition Obsessive-Compulsive Disorder
Intervention Other: OC-Go
OC-Go, a HIPAA-compliant web-based clinician portal and patient-side mobile application that allows clinicians to create and push tailored treatment assignments to patients on their mobile devices
Study Groups/Cohorts OC-Go
Approximately 10-20 9-17 year-olds receiving exposure based cognitive behavior therapy for OCD through the UCLA Division of Child and Adolescent Psychiatry OCD treatment programs
Intervention: Other: OC-Go
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Enrolling by invitation
Estimated Enrollment
 (submitted: April 19, 2017)
15
Original Estimated Enrollment Same as current
Estimated Study Completion Date March 31, 2020
Estimated Primary Completion Date February 1, 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Children receiving exposure based CBT through the UCLA Child OCD, Anxiety and Tic Disorders Clinic or Pediatric OCD Intensive Outpatient Program and their parents

Exclusion Criteria:

  • None
Sex/Gender
Sexes Eligible for Study: All
Ages 9 Years to 17 Years   (Child)
Accepts Healthy Volunteers Not Provided
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT03126305
Other Study ID Numbers R42MH111277-01A1( U.S. NIH Grant/Contract )
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: No
Responsible Party John Piacentini, University of California, Los Angeles
Study Sponsor University of California, Los Angeles
Collaborators Virtually Better, Inc.
Investigators
Principal Investigator: John Piacentini, Ph.D. University of California, Los Angeles
Principal Investigator: Peter Tuerk, Ph.D. Virtually Better, Inc.
PRS Account University of California, Los Angeles
Verification Date June 2018